2,492 research outputs found

    Design of a single ultra-low-loss magnetic ballast for a wide range of T5 high-efficiency fluorescent lamps

    Get PDF
    A patent-pending single design of an ultralow-loss (ULL) magnetic ballast for T5 high-efficient (T5-HE) fluorescent lamps rated from 14 to 35 W is presented. Based on the use of a nonlinear physical low-pressure discharge lamp model, it is discovered that the same set of ballast parameters can be chosen for operating T5-HE 14-, 21-, 28-, and 35-W lamps at their respective rated power at a mains voltage in the range of 220-240 V. With energy efficiency higher than and lifetime much longer than their electronic counterparts and being recyclable, the ULL ballasts offer a more environmentally friendly solution to T5-HE lamps than electronic ballasts. This single-ballast design offers great convenience to both ballast manufacturers and users, because only one product design can cover a range of the most popular T5-HE lamps. Both theoretical analysis and experimental results are included to confirm the validity of the proposal. © 2011 IEEE.published_or_final_versio

    A "Class-A2" ultra-low-loss magnetic ballast for T5 fluorescent lamps - A new trend for sustainable lighting technology

    Get PDF
    The high-voltage and low-current features of T5 lamps imply that the copper and core losses of the magnetic ballast can be greatly reduced. This paper shows that magnetic ballasts for high-voltage T5 lamps are not only feasible but their luminous and ballast-loss performance can be better than those of the electronic ballasts. Contrary to common belief, high frequency operation of T5 28 W lamps increases the luminous efficacy by an average of 3.6% only (less than 5%). Practical implementation of an ultra-low-loss magnetic ballast system for T5 28 W lamps is presented. Its total system power is less than the 32 W upper limit specified for Class A2 of energy-efficient electronic ballast for T5 28 W lamps. High-luminous efficacy of 75.63-77.66 lm/W can be achieved. This important breakthrough has the potential of reversing the existing trend of using electronic ballasts as the energy-saving technology in lighting industry. With a better luminous efficacy, lower product and maintenance costs, much longer lifetime, and the use of recyclable metallic materials over its electronic counterparts, this patent-pending proposal provides a truly sustainable lighting solution to the lighting industry. © 2006 IEEE.published_or_final_versio

    Skin banking in Hong Kong - the development and experience in Queen Mary Hospital

    Get PDF
    published_or_final_versio

    A "Class-A2" ultra-low-loss magnetic ballast for T5 fluorescent lamps - A new trend for sustainable lighting technology

    Get PDF
    The high-voltage and low-current features of T5 lamps imply that the copper and core losses of the magnetic ballast can be greatly reduced. This paper shows that magnetic ballasts for high-voltage T5 lamps are not only feasible but their luminous and ballast-loss performance can be better than those of the electronic ballasts. Contrary to common belief, high frequency operation of T5 28 W lamps increases the luminous efficacy by an average of 3.6% only (less than 5%). Practical implementation of an ultra-low-loss magnetic ballast system for T5 28 W lamps is presented. Its total system power is less than the 32 W upper limit specified for Class A2 of energy-efficient electronic ballast for T5 28 W lamps. High-luminous efficacy of 75.63-77.66 lm/W can be achieved. This important breakthrough has the potential of reversing the existing trend of using electronic ballasts as the energy-saving technology in lighting industry. With a better luminous efficacy, lower product and maintenance costs, much longer lifetime, and the use of recyclable metallic materials over its electronic counterparts, this patent-pending proposal provides a truly sustainable lighting solution to the lighting industry. © 2006 IEEE.published_or_final_versio

    Parental pro-smoking practices and smoking susceptibility among children in Hong Kong

    Get PDF
    Conference Theme: Tobacco and Non-Communicable DiseasesPoster Discussion 61. Assessing the Factors that Influence Tobacco Use: no. PD-1313-21BACKGROUND: Parental influence on children smoking is well known, but most studies focused on general parenting and less on smoking-specific parental practices. We investigated the association between some parental pro-smoking practices (PPP) and children smoking susceptibility. DESIGN/METHODS: Among 100 primary schools with students viewing an anti-smoking drama performance commissioned by the Hong Kong Council on Smoking and Health in 2012/13, 7 were randomly selected and 1255 primary 2-4 students (mean age 8.5±0.02, 42.8% boys) completed an anonymous self-administered questionnaire. Fifteen specific items of PPP in the past 30 days were …published_or_final_versio

    Use of deltopectoral flap for head and neck reconstruction

    Get PDF
    Theme: Challenges to specialists in the 21st centurypublished_or_final_versio

    Primary hyperaldosteronism among Chinese hypertensive patients: how are we doing in a local district in Hong Kong

    Get PDF
    OBJECTIVES: To estimate the point prevalence of primary hyperaldosteronism in a government out-patient setting and to compare associated patient characteristics with those having essential hypertension. DESIGN: Case series with external comparison. SETTING: A single public hospital (Caritas Medical Centre) and all five associated general out-patient clinics in Sham Shui Po district in Hong Kong. PATIENTS: All patients with confirmed primary hyperaldosteronism and randomly selected patients with essential hypertension from a medical specialist clinic and general out-patient clinics, retrieved from a computer database for the period January 2007 to December 2008. MAIN OUTCOME MEASURES: Estimated point prevalence of primary hyperaldosteronism among hypertensive patients treated in the public sector of Sham Shui Po district. Patient age when hypertension was diagnosed, number of antihypertensive drugs used for treatment, and the presence of target organ damage in the patients with primary hyperaldosteronism and those with essential hypertension were compared. RESULTS: Among the 46 012 patients receiving antihypertensive treatment, 49 were confirmed to have primary hyperaldosteronism. The estimated point prevalence of primary hyperaldosteronism among these hypertensive patients was 0.106% only, which was far smaller than figures from other countries. When compared with the 147 patients with essential hypertension by multivariate analysis, those with primary hyperaldosteronism were: (1) associated with longer durations of hypertension (odds ratio=1.14; 95% confidence interval, 1.06-1.24) despite being younger at the time of study, (2) likely to be taking three or more antihypertensive drugs (odds ratio=2.51; 95% confidence interval, 1.59-3.95), and (3) more likely to have left ventricular hypertrophy (odds ratio=5.01; 95% confidence interval, 1.83-13.69). All primary hyperaldosteronism patients studied presented with hypokalaemia. The need for antihypertensive drugs was markedly reduced after adrenalectomy for adrenal adenoma. CONCLUSIONS: Primary hyperaldosteronism, which is potentially a surgically curable cause of hypertension, appeared to be underdiagnosed in our locality. Screening by aldosterone-renin ratio of high-risk individuals may help improve patient outcomes.published_or_final_versio

    Helicobacter pylori infection is associated with increased expression of macrophage migratory inhibitory factor - by epithelial cells, T cells, and macrophages - in gastric mucosa

    Get PDF
    The macrophage migratory inhibitory factor (MIF) plays a pivotal role in inflammatory and immune diseases; however, its role in gastrointestinal diseases has not been clarified. This study intended to determine the expression of MIF, by gastric epithelial cells, T cells, and macrophages, in Helicobacter pylori-induced gastritis. Sixty-four patients (30 males, 34 females; mean age, 47 years) referred for upper endoscopy were recruited. Biopsy specimens from the gastric antrum and corpus were obtained for (1) detection of H. pylori and histological examination, (2) single and double immunostaining to test for expression of MIF protein in epithelial cells, T cells, and macrophages, and (2) in situ hybridization for expression of MIF mRNA within the lamina propria. In mucosal specimens from each of the 2 sites, both the percentage of MIF + epithelial cells and the numbers of MIF mRNA+ inflammatory cells, MIF+ T cells, and MIF+ macrophages were significantly higher in H. pylori-positive patients than in H. pylori-negative patients. Overall, the percentage of MIF+ epithelial cells and the numbers of MIF mRNA+ cells, MIF+ T cells, and MIF+ macrophages were higher in the antrum than in the corpus. The percentage of MIF+ epithelial cells and the numbers of MIF mRNA+ cells, MIF+ T cells, and MIF+ macrophages increased in chronic gastritis, but, in the absence of H. pylori infection, this increase disappeared for all except MIF+ T cells. Therefore, H. pylori infection is associated with increased expression of the MIF protein and MIF mRNA in gastric epithelial and inflammatory cells; along with other cytokines, MIF may play a significant role in gastric inflammation related to H. pylori infection.published_or_final_versio

    Nasopharyngeal carcinoma: presenting symptoms and duration before diagnosis

    Get PDF
    This is a retrospective analysis of 4768 patients with undifferentiated or non-keratinising carcinoma of the nasopharynx who were treated during 1 January 1976 to 31 December 1985. The mean duration of symptoms before diagnosis was 8 months (range, 1-36 months for 95% of patients). A significant association between the duration of symptoms and the presenting stage was observed (P<0.001); 58% and 39% of stage I and stage V patients, respectively, reported as having had symptoms for less than 6 months. Of the later presenters (those having had symptoms for 6 months or longer), 89% were given a full course of radical megavoltage radiotherapy, but 6% were too advanced for any irradiation attempt. Consequently, the 10-year actuarial disease-specific survival was significantly higher among the early presenters: 48% versus 42% (P<0.001). The importance of early detection is emphasised.published_or_final_versio
    • …
    corecore